The incidence of malignant melanoma has been rising over thepast three decades.1 Much of the increase is accounted for bythin, localized cutaneous melanomas with the potential to becured by surgery. Once melanoma spreads beyond the primary lesion,however, the likelihood of cure decreases dramatically. Five-yearrelative survival rates for patients with melanoma in the UnitedStates between 1992 and 1998 were 96 percent for those withlocal lesions but only 60 percent for patients whose melanomashad spread regionally and 14 percent for those with distantmetastases.1 The thickness of the tumor and the presence orabsence . . . [Full Text of this Article]
Source Information
From the Clinical Immunology Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York.
Hellman, S., Hurt, M. A., Thomas, J. M., A'Hern, R., Newton-Bishop, J.
(2004). Excision Margins in High-Risk Malignant Melanoma. NEJM
350: 2305-2306
[Full Text]
(2004). What Is the Optimal Excision Margin for Thick Melanomas?. JWatch General
2004: 6-6
[Full Text]